We're sorry but RePORTER doesn't work properly without JavaScript enabled. Please enable it to continue.
Skip Navigation Links
NIH
RePORT
RePORTER
Toggle
FAQs
API
ExPORTER
Sign In
Public Users...
Sign in with Login.gov
NIH Staff...
Sign in with NIH Login
Search Results
4 Projects
Save...
Export
Share
Email
Copy Link
Search
Projects
Publications
Patents
Clinical Studies
News & More
List
Charts
Map
Filters
Filters
Active Projects
Fiscal Years
2024
(1)
2023
(2)
2022
(1)
Org Names
INSTITUTE FOR MOLECULAR MEDICINE
(4)
Agencies
NIH
(4)
expand
NIH/NIA
(4)
States
CA
(4)
Countries
UNITED STATES
(4)
Principal Investigators
AGADJANYAN, MICHAEL G
(4)
T
Act
Project
Year
Sub
Principal Investigator(s)/ Project Leader(s)
Organization
Fiscal Year
Admin IC
Funding IC
FY Total Cost by IC
Similar Projects
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
5
Tf
R01
Actf
AG074983
Projectf
03
Yearf
AGADJANYAN, MICHAEL G
Principal Investigator(s)/ Project Leader(s)
SCHNEIDER, LON S
Principal Investigator(s)/ Project Leader(s)
SULTZER, DAVID
Principal Investigator(s)/ Project Leader(s)
INSTITUTE FOR MOLECULAR MEDICINE
2024
NIA
NIA
$2,243,861
View
View Similar Projects
Similar Projectsf
Manufacturing of New Batch AV-1959D Drug Product and Placebo for Phase 1 Trial
3
Tf
R01
Actf
AG074983
Projectf
02S1
Yearf
AGADJANYAN, MICHAEL G
Principal Investigator(s)/ Project Leader(s)
SCHNEIDER, LON S
Principal Investigator(s)/ Project Leader(s)
SULTZER, DAVID
Principal Investigator(s)/ Project Leader(s)
INSTITUTE FOR MOLECULAR MEDICINE
2023
NIA
NIA
$699,000
View
View Similar Projects
Similar Projectsf
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
5
Tf
R01
Actf
AG074983
Projectf
02
Yearf
AGADJANYAN, MICHAEL G
Principal Investigator(s)/ Project Leader(s)
SCHNEIDER, LON S
Principal Investigator(s)/ Project Leader(s)
SULTZER, DAVID
Principal Investigator(s)/ Project Leader(s)
INSTITUTE FOR MOLECULAR MEDICINE
2023
NIA
NIA
$2,408,617
View
View Similar Projects
Similar Projectsf
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
1
Tf
R01
Actf
AG074983
Projectf
01
Yearf
AGADJANYAN, MICHAEL G
Principal Investigator(s)/ Project Leader(s)
SCHNEIDER, LON S
Principal Investigator(s)/ Project Leader(s)
SULTZER, DAVID
Principal Investigator(s)/ Project Leader(s)
INSTITUTE FOR MOLECULAR MEDICINE
2022
NIA
NIA
$2,680,709
View
View Similar Projects
Similar Projectsf
T
Act
Project
Year
Sub
Principal Investigator(s)/ Project Leader(s)
Organization
Fiscal Year
Admin IC
Funding IC
FY Total Cost by IC
Similar Projects
Export
Select options for export:
Format:
CSV
Excel
Columns:
Projects To Download:
15000 (max records)
Export Search Criteria:
export search criteria
Close
Export